Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well paint me shocked because if it doubled that would be a significant increase!
Smart, I play pennies but I also play safer stocks too. However, I am just starting out and am about even.
It's a slow arduous process when you are teaching yourself everything.
I will be evaluating her article later since I have access to it.
Here is the about of the journal she was published in:
http://www.jocmr.org/index.php/jocmr/pages/view/editorialTeam
It will be curious the results and look at the statistical analysis.
Where to find her article:
Volume 9, Number 8, August 2017, pages 701-708
I am sorry to hear that. My brother passed away for the same reason. My condolences to you and his family.
We may need to get out an AED and preform life saving measures!
Kool Aid- come on, just this once breathe some life into this. It's no fun for you if its dead in here!
Emit, I appreciate your posts so I hope I do not sound dismissive however RRT require a terminal illness.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870193/
www.pccef.org/resources/documents/PRCUpdate_2011_4pg4-5.pdf
I do not think CHF is considered that unless their prognosis shows a rapid decline of ADLs or other specific biological indicators and all 1st, 2nd, and 3rd lines of diuretics and CFH management have failed. I will have to explore this further since I can admit I do not know how they would define it from the lens of putting someone on palliative care.
http://ascopubs.org/doi/full/10.1200/jco.2015.62.8057
What does terminally ill mean? Please illuminate me oh lord of knowledge.
My partner is a cardiac nurse in a EP/Cardiac clinic and I work in complex medical cases. Trust me, I know what can and cannot be done.
It's a wonderful treatment and can provide a lot of relief but it's not saving lives. It would require improving the tech & have a cohort- double blind, TAU vs Myocell type of study. Those are expensive and take time. The only way to distill that information is beyond the company at this time.
True, though it is the summer and it blew it's proverbial load early. I still think we are going lower but I have a strike price if we do!
Hope you are having a good summer over there Kool Aid Man. Keep poking the bulls in here with your bearish attitude. I appreciate it since someone has to :P
It appears we have closed where we opened. So, what do you think?
It's considered a chronic disease. It kills a lot of people but it can be managed via current treatments. Thus, it may not be a priority since it has cheap alternatives.
No disrespect taken. It's okay to have different views. I work in the medical field and is the reason I was attracted to this company. There are two frameworks in which I view a company: How good of leadership do you have? Are they the type to be concise, accurate, and able to right a ship? Also, how well do I understand the product and business plan. The latter on this company is where I had the proper framework but the leadership of this company gets an F. Poor leadership and sink any ship no matter how well built it is to stay afloat.
I have always appreciated your posts on here and hopefully the trend will reverse. I only plan on buying more if it hits 1-2 cents because I think that is fair value given its current state.
What are your projections and hopefully you have other investments which have been able to absorb some of these losses.
I was hoping for an interpretive painting dance then a roll of chicken bones to read me the future. I guess I will just have to wait to see if it really was a paint job.
To my understanding their catheters are the primary source of revenue. Also, the services they sale- to my knowledge- is consultation services.
I will have to revisit their company info again because it's been a while since I thoroughly researched the company.
Please fill in my gaps because I may be missing some info.
Hey Docprep,
I am in the same boat. However, I do not have a large investment like some do in here. I may end up averaging down in case there is a camels back that pops up somewhere down the line but I think we are both sitting on dead money for now. I am not sure what has happened can be fixed without RMAT designation or an amazing quarterly, which I doubt the latter. Good luck with everything my friend. I hope you can recoup some losses.
All very fair critiques. It's worrisome because the politics of getting a drug approved may hamper this company for a long time. Also, even with these right to try laws I am unsure where this tech would fall. I am not sure it's considered an acute disease which cannot be controlled with conventional means(CHF)therefor the feds could come down on the company like a asteroid coming down on the earth.
Could you please spell it out for me?
Thank you.
The interesting thing is there can be a lawsuit for multiple reasons but I will just link you 5 different class actions shareholders have put forth because of companies acting in a shady manner:
First some background:
http://smallbusiness.chron.com/classaction-vs-derivative-shareholder-lawsuits-72779.html
Now real world examples:
http://watchdog.org/286630/southern-company-5/
http://www.fiercepharma.com/pharma/shareholders-sue-strugglig-perrigo-for-misleading-them-away-from-mylan-buy
http://www.businessinsider.com/sears-ceo-will-pay-40-million-to-settle-shareholder-lawsuit-2017-2
https://www.hbsslaw.com/cases/theranos/pressrelease/theranos-court-upholds-fraud-claims-in-investor-class-action-lawsuit-against-theranos-ceo-elizabeth-holmes-and-other-officers
Point is- if someone has lost a reasonable amount of money because of the negligence of the CEO they are entitled to move forward with litigation.
It's the reality of the system we live in.
I foresee a class action lawsuit on it's way. This company is going to get tanked by their own stupidity. There are only ruining confidence on their ability to run a company appropriately. I'll just forget I own any shares while this drops to sub-penny, the cycle continues.
This stock has acted as I have expected it to. It's unfortunate but the reality of the situation. I commend it for sticking in the range it has. I did expect a few dips lower. GLTA
I hope you folks had a wonderful 4th. I spent mine enjoying a drink of bourbon from ROX and rested. Hope the board did as well!
So I finally checked out the 4th of July commercial the company posted on Facebook. Personally, I feel they could use Wieden and Kennedy to help them brand better. I was not impressed with it at all. However, I am impressed with their products!
I am debating where I want to renter. I have a good amount of shares right now so I may wait until it rides down, if it does.
If I was a betting man I would say those bid whacks are meaningless.
I think most of that volume happened in the last 2 hrs of trading. Today's volume is pretty light surprisingly. Also, Soldier- I will let you know what I hear.
I have come to like your critiques Kool Aid Man. I am not sure what your motives are but we need a voice of decent in every stock. If things are always rainbows and unicorns there is something fishy going on.
I am going to purchase more shares if it hits .001 or less. I hope the business is successful since new industries are always good to have. Hemp and MJ are amazing industrial plants so if they are commercially successful we all benefit.
A slow accumulation of shares is how I am approaching ROX. Hopefully the PPS will stay down here until the money clears in my account so I can average down some more.
Gotham, thank you for your well thought out response. To my understanding the quality of data for the EPI results are of a higher quality. I have not played around with the source data in any statistical software however they provide their methods & source data if you are interested in it here:
http://www.epi.org/publication/income-inequality-in-the-us/
Anyways, that conversation is for another time. To your point- the business model is sound if they are able to practice freely. I am concerned about regulatory issues that it may fall under. I need to educate myself more regarding the "Right to Try" laws. I lack a great deal of understanding in this regards.
I agree if they are to find any success TX and FL would be ideal.
Thanks for chiming in. It seems you earned a follower.
I agree, typically urban centers have higher incomes due to what economic sectors are found within them. It will be an interesting year or two with this company.
Average income in Texas is 53,000.
https://www.census.gov/quickfacts/table/PST045216/48
Regarding your last point. There is a big difference in disease burden based off of socioeconomics. A quick internet search dredged this up:
https://www.researchgate.net/publication/11391471_What_do_we_know_about_socioeconomic_status_and_congestive_heart_failure_A_review_of_the_literature
It appears to be a lit review.
Based on the levels of evidence levels this would be only a level 3. It's interesting regardless if this is your thing (obviously it's mine)
I would need to read up more on the details of the company but the fact still remains those who make more than 86k are in a different quartile.
Below is a cool tool regarding income demographics.
http://graphics.wsj.com/what-percent/
http://www.epi.org/multimedia/unequal-states-interactive/#/Texas
Where are you getting the 20k figure- I am not sure I have seen the procedural number and typically there is a great deal of variance here in the U.S. in regards to procedures.
Thanks for the thoughtful response- real conversations are appreciated.
Maybe you should read it because it's not about the women who had a negative outcome but how crappy the company has responded, the fact it was not supposed to be used on those with eyesight, period.
"But the ICMS IRB was chastised by the FDA in June 2012 for approving a stem cell clinical trial that the agency had shut down three years before. That letter documented a series of problems with the IRB’s procedures, including granting approval without the required quorum of members being present."
"A July 2016 court filing by Patsy Bade, after she had settled with US Stem Cell but before her settlement with Greenbaum, alleges that the trial did start enrolling patients. It indicates that Greenbaum was convinced by Comella — they met at the gym where Comella was an aerobics instructor, according to the court document — to become the trial’s lead researcher. Greenbaum was allegedly trained by Comella in how to harvest and use stem cells from fat, with the $7,500 cost being deferred in exchange for Greenbaum agreeing to work on the clinical trial."
I am more upset with personal behavior than I am with the company.
Interesting although it's a very select amount of folks that can access their services:
https://www.nerdwallet.com/blog/loans/prosper-personal-loans-review/
"Have substantial annual income. The average for Prosper borrowers is $86,400. There’s no minimum requirement, but borrowers generally have high incomes and experience with multiple lines of credit."
"The U.S. Census Bureau reported in September 2014 that: U.S. real (inflation adjusted) median household income was $51,939 in 2013 versus $51,758 in 2012, statistically unchanged. In 2013, real median household income was 8.0 percent lower than in 2007, the year before the latest recession."
Those who need it likely are middle or low income Americans since they traditionally have poorer health outcomes than those who would be considered upper or upper middle class.
Hence, it's not a huge business line we are talking about here. CMS, BCBS, and other large health insurers would be where actual revenue from reimbursement would help.
It's unlikely those who need this (if it actually has reproducible outcomes- side note that is an issue lately with a lot of research) will only have access through insurance.
It's okay- I was considering it when it was back at 3 cents but as a broke @ss college student I can only dream of playing it big.
With that being said I have become more wary of USRM.
I am glad for the 4 green days in a row but we can all critique what we love to make it better. I bought in at a higher share price before the CEO tanked the stock.
I found this article while doing some DD.
https://www.buzzfeed.com/peteraldhous/stem-cell-tragedy-in-florida?utm_term=.tg2Nmwq2d#.qbBloVArX
Formulate your own opinions.
Also, for furthering your stem cell education here are some summits that have world renow leaders in the industry speaking. Explore the scientist in the field.
https://www.gtcbio.com/conferences/stem-cell-summit-2017/
http://worldstemcellsummit.com/speakers/
Good luck to all- hopefully we actually get some real news soon. Also, has anyone check Edgar lately?
I been following Kristin's blogs/posts and to be frank I am worried about her scientific literacy since some of her posts are opposed to the body of evidence out there. Of course you can be a genius in one realm of the world and a novice in the other.
Hey Funnman and Soldier-
Gosling and Jefferson's were a hit with the folks I camped with.
To bad the stock has taken a hit! I was thinking we might rebound to around $2 bucks a share!
Or major crashes unfortunately.
I still have faith in the company but the SP is going to be trashed for a while. I was going to pull out last week but got lazy lol
Very likely unfortunately. I still see opportunity here but dang- I bought in at the 7's and I am going to average down when it stabilizes. Who knows where the bottom is here.
I can dig it. I plan on taking some Jefferson's & Gosling camping with me this week and I'll be shamelessly plugging ROX.
I went to a festival a few years ago and Tito's vodka was being promoted. I ended up hanging out with one of the co-owners all night having drinks. I'll be Jefferson's guy this week.
I say we can call it the "Soldier Hard Method" which developed by philanthropist and soldier XYZ in 2017. This method was developed to evaluate how a stocks future performance correlates with it's 3 month historical chart behavior.
The Funman Method was...
Happy trading this week!